SB-681323-Methotrexate Interaction Study
clinical trial
Press Enter · cited answer in seconds
0 sources
SB-681323-Methotrexate Interaction Study
Summary
SB-681323-Methotrexate Interaction Study is a clinical trial[1].
Key Facts
- SB-681323-Methotrexate Interaction Study is in the country of Australia[2].
- SB-681323-Methotrexate Interaction Study's instance of is recorded as clinical trial[3].
- SB-681323-Methotrexate Interaction Study's start time is recorded as +2005-05-31T00:00:00Z[4].
- SB-681323-Methotrexate Interaction Study's end time is recorded as +2005-12-31T00:00:00Z[5].
- SB-681323-Methotrexate Interaction Study's sponsor is recorded as GSK[6].
- SB-681323-Methotrexate Interaction Study's main subject is recorded as arthritis[7].
- SB-681323-Methotrexate Interaction Study's number of participants is recorded as {'unit': '1', 'amount': '+18'}[8].
- SB-681323-Methotrexate Interaction Study's title is recorded as A Placebo Controlled Study to Evaluate the Safety and Tolerability of Repeat Doses of SB-681323 in Patients Receiving Methotrexate for Rheumatoid Arthritis.[9].
- SB-681323-Methotrexate Interaction Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- SB-681323-Methotrexate Interaction Study's ClinicalTrials.gov ID is recorded as NCT00419809[11].
- SB-681323-Methotrexate Interaction Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[12].
- SB-681323-Methotrexate Interaction Study's research intervention is recorded as methotrexate[13].
- SB-681323-Methotrexate Interaction Study's clinical trial phase is recorded as phase I clinical trial[14].
- SB-681323-Methotrexate Interaction Study's research site is recorded as GSK[15].
- SB-681323-Methotrexate Interaction Study's research subject recruitment status is recorded as completed[16].
- SB-681323-Methotrexate Interaction Study's study type is recorded as interventional study[17].